AstraZeneca

AstraZeneca 'provided' outdated vax data for trial: Top US agency

US-based National Institute of Allergy and Infectious Diseases (NIAID) expressed concern on Tuesday that British-Swedish pharmaceutical major AstraZeneca may have provided outdated information on the efficacy data related to the clinical trial of its Covid-19 vaccine, which may have provided an incomplete view of the efficacy data. Mar 23, 2021
AstraZeneca

AstraZeneca Vaccine Found 79% Effective In US Trials

The vaccine was 100% effective against severe or critical disease and hospitalisation and was safe, the drugmaker said on Monday, releasing results of the late-stage human trial study of more than 32,000 volunteers across all age groups. Mar 22, 2021